96 related articles for article (PubMed ID: 20593558)
1. Study confirms link between certain diabetes drugs and fractures.
Harv Womens Health Watch; 2010 May; 17(9):6. PubMed ID: 20593558
[No Abstract] [Full Text] [Related]
2. [Thiazolidinediones and skeletal health].
Meier C; Bodmer M; Meier CR; Kraenzlin ME
Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk is a class effect of glitazones.
Short R
BMJ; 2007 Mar; 334(7593):551. PubMed ID: 17363794
[No Abstract] [Full Text] [Related]
4. Considering competing risks . . . Not all black and white.
Cauley JA; Ensrud KE
Arch Intern Med; 2008 Apr; 168(8):793-5. PubMed ID: 18443252
[No Abstract] [Full Text] [Related]
5. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
[TBL] [Abstract][Full Text] [Related]
6. Diabetes drug pioglitazone (Actos): risk of fracture.
Meymeh RH; Wooltorton E
CMAJ; 2007 Sep; 177(7):723-4. PubMed ID: 17823139
[No Abstract] [Full Text] [Related]
7. Use of thiazolidinediones and fracture risk.
Meier C; Kraenzlin ME; Bodmer M; Jick SS; Jick H; Meier CR
Arch Intern Med; 2008 Apr; 168(8):820-5. PubMed ID: 18443256
[TBL] [Abstract][Full Text] [Related]
8. Diabetes drug safety update: Avandia and your heart.
Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316
[No Abstract] [Full Text] [Related]
9. Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation.
Kaul S; Bolger AF; Herrington D; Giugliano RP; Eckel RH
Circulation; 2010 Apr; 121(16):1868-77. PubMed ID: 20179252
[No Abstract] [Full Text] [Related]
10. Research profile. Is there a link? TZDs and congestive heart failure. Andrew Karter, PhD.
Kordella T
Diabetes Forecast; 2004 Jun; 57(6):98-100. PubMed ID: 15195634
[No Abstract] [Full Text] [Related]
11. Distal upper and lower limb fractures associated with thiazolidinedione use.
Jones SG; Momin SR; Good MW; Shea TK; Patric K
Am J Manag Care; 2009 Aug; 15(8):491-6. PubMed ID: 19670952
[TBL] [Abstract][Full Text] [Related]
12. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
Misbin RI
Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
[No Abstract] [Full Text] [Related]
13. Thiazolidinedione use and the risk of fractures.
Reblin T
CMAJ; 2009 Apr; 180(8):841. PubMed ID: 19364797
[No Abstract] [Full Text] [Related]
14. Rosiglitazone and pioglitazone. Beware fractures.
Dixit A; Pandey P
BMJ; 2009 Sep; 339():b3957. PubMed ID: 19808816
[No Abstract] [Full Text] [Related]
15. Thiazolidinediones: do harms outweigh benefits?
Lipscombe LL
CMAJ; 2009 Jan; 180(1):16-7. PubMed ID: 19073650
[No Abstract] [Full Text] [Related]
16. Thiazolidinedione-induced skeletal fragility--mechanisms and implications.
Grey A
Diabetes Obes Metab; 2009 Apr; 11(4):275-84. PubMed ID: 18671797
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
Kahn SE; Zinman B; Lachin JM; Haffner SM; Herman WH; Holman RR; Kravitz BG; Yu D; Heise MA; Aftring RP; Viberti G;
Diabetes Care; 2008 May; 31(5):845-51. PubMed ID: 18223031
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones.
Mascitelli L; Pezzetta F
N Engl J Med; 2005 Jan; 352(2):205-7; author reply 205-7. PubMed ID: 15651125
[No Abstract] [Full Text] [Related]
19. Thiazolidinedione use and the risk of fractures.
Toulis KA; Goulis DG; Anastasilakis AD
CMAJ; 2009 Apr; 180(8):841-2; author reply 842-3. PubMed ID: 19364796
[No Abstract] [Full Text] [Related]
20. Rosiglitazone: failure of oversight or demons imagined?
Susman J
J Fam Pract; 2007 Sep; 56(9):696, 703. PubMed ID: 17764640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
